covid19serohub.nih.gov Open in urlscan Pro
2600:9000:21f3:a00:18:bd4e:540:93a1  Public Scan

Form analysis
0 forms found in the DOM

Text Content

We're sorry but COVID-19 SeroHub doesn't work properly without JavaScript
enabled. Please enable it to continue.


COVID-19 SEROHUB

COVID-19 SeroHub is using the most recent data from CDC and other sources, data
last updated: 11/21/2022    Data Version: 3.1.0

The COVID-19 Seroprevalence Studies Hub, known as COVID-19 SeroHub, is an online
dashboard intended to help researchers and policymakers monitor studies of
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence in
the United States. These types of studies use blood tests to identify the
proportion of people in the population who possess antibodies to SARS-CoV-2.
Estimates of seroprevalence do not necessarily indicate the percentage of people
with sufficient antibody to protect against infection.

If you would like to have your study included in COVID-19 SeroHub, please
complete our Study Submission Template.

The following is a list of studies that are scheduled to appear on the dashboard
as soon as they fully progress through our team’s review life cycle.

COVID-19 SeroHub is a collaboration of the Centers for Disease Control and
Prevention, the National Cancer Institute and National Institute of Allergy and
Infectious Diseases, part of the National Institutes of Health. The team has
developed a Standard Operating Procedure which captures the process we will use
to identify, abstract, and standardize information from studies.

View pediatric data across studies on SeroHub at Pediatric Data Page.

Aim 1

To systematically identify published and ongoing SARS-CoV-2 seroprevalence
studies.

Aim 2

To offer an interactive dashboard to visualize SARS-CoV-2 seroprevalence
estimates over time and by geography, population, and other factors.

INTERACTIVE SEROPREVALENCE TOOL
STUDIES MAP
STUDY INFORMATION
SEROPREVALENCE DATA


This is an interactive tool displaying seroprevalence values by calendar time
for the studies in this database. Some studies contribute multiple
seroprevalence estimates (for example, in different parts of the country and at
different times).

Antigen Target Study Population

Toggle to view seroprevalence estimates marked by antigen target or study
population


FILTERS

Use the options below to select the data displayed on the graph

Age (0)

Sex (0)


Female

Male

Not Specified
Race / Ethnicity(0)

Antigen Target (4)

Population (0)

Geography (0)

Report Type (0)

Special Collections (0)

Test Type (0)

Antibody Isotypes (0)

Reset filters
Overall
Age
Sex
Race / Ethnicity


Showing 0 of 0 values, 4 filters applied.

View Data As Accessible Text


National Cancer Institute
at the National Institutes of Health


BROWSER COMPATIBILITY

Latest versions of Chrome, Edge, Firefox, Safari, Opera


POLICIES

 * Accessibility
 * Disclaimer
 * FOIA
 * HHS Vulnerability Disclosure
 * Privacy & Security


HELP AND SUPPORT

 * COVID19SeroHub-Support@nih.gov
 * LAST BUILD
 * 02-21-23 12:21


AGENCIES

 * U.S. Department of Health and Human Services|
 * National Institutes of Health|
 * National Cancer Institute|
 * USA.gov